Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Keeble

Showing results (81-90 of 131) with videos related to

Pageof 14
Sort By:
Cardiovascular Intervention and Therapeutics|December 23, 2025
Absolute coronary blood flow measurement and the principle of microvascular resistance reserveNico H J Pijls, Danielle C J Keulards, Tsunekazu Kakuta, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 14, 2022
A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trialAlexandra N Nowbar, Christopher Rajkumar, Michael Foley, et al.
Critical Care (London, England)|August 26, 2023
Neuropsychological outcome after cardiac arrest: results from a sub-study of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trialErik Blennow Nordström, Susanna Vestberg, Lars Evald, et al.
Journal of the American College of Cardiology|April 22, 2026
Focal and Diffuse Coronary Artery Disease Patterns and Placebo-Controlled Angina Relief With Percuatenous Coronary Intervention: ORBITA-2Kayla Chiew, Michael J Foley, Shayna Chotai, et al.
European Heart Journal. Digital Health|January 30, 2023
Daily angina documentation versus subsequent recall: development of a symptom smartphone appAlexandra N Nowbar, James P Howard, Matthew J Shun-Shin, et al.
Intensive Care Medicine|April 28, 2025
Intravascular vs. surface cooling in out-of-hospital cardiac arrest patients receiving hypothermia after hospital arrival: a post hoc analysis of the TTM2 trialAkil Awad, Martin Jonsson, Johan Holgersson, et al.
Journal of the American Heart Association|April 23, 2020
Recovery of Absolute Coronary Blood Flow and Microvascular Resistance After Chronic Total Occlusion Percutaneous Coronary Intervention: An Exploratory StudyDaniëlle C J Keulards, Grigoris V Karamasis, Osama Alsanjari, et al.
Critical Care (London, England)|October 15, 2024
Hypothermia versus normothermia in patients with cardiac arrest and shockable rhythm: a secondary analysis of the TTM-2 studyFabio Silvio Taccone, Alain Cariou, Stefano Zorzi, et al.
Resuscitation Plus|June 18, 2025
Psychometric evaluation of EQ-5D-5L in OHCA survivors from the TTM2 trial: a <i>post hoc</i> analysisMattias Bohm, Kristofer Årestedt, Susann Ullén, et al.
Journal of the American Heart Association|January 26, 2021
Achieving Optimal Medical Therapy: Insights From the ORBITA TrialMichael Foley, Christopher A Rajkumar, Matthew Shun-Shin, et al.
Pageof 14

Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Cardiovascular Intervention and Therapeutics|December 23, 2025
Absolute coronary blood flow measurement and the principle of microvascular resistance reserveNico H J Pijls, Danielle C J Keulards, Tsunekazu Kakuta, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 14, 2022
A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trialAlexandra N Nowbar, Christopher Rajkumar, Michael Foley, et al.
Critical Care (London, England)|August 26, 2023
Neuropsychological outcome after cardiac arrest: results from a sub-study of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trialErik Blennow Nordström, Susanna Vestberg, Lars Evald, et al.
Journal of the American College of Cardiology|April 22, 2026
Focal and Diffuse Coronary Artery Disease Patterns and Placebo-Controlled Angina Relief With Percuatenous Coronary Intervention: ORBITA-2Kayla Chiew, Michael J Foley, Shayna Chotai, et al.
European Heart Journal. Digital Health|January 30, 2023
Daily angina documentation versus subsequent recall: development of a symptom smartphone appAlexandra N Nowbar, James P Howard, Matthew J Shun-Shin, et al.
Intensive Care Medicine|April 28, 2025
Intravascular vs. surface cooling in out-of-hospital cardiac arrest patients receiving hypothermia after hospital arrival: a post hoc analysis of the TTM2 trialAkil Awad, Martin Jonsson, Johan Holgersson, et al.
Journal of the American Heart Association|April 23, 2020
Recovery of Absolute Coronary Blood Flow and Microvascular Resistance After Chronic Total Occlusion Percutaneous Coronary Intervention: An Exploratory StudyDaniëlle C J Keulards, Grigoris V Karamasis, Osama Alsanjari, et al.
Critical Care (London, England)|October 15, 2024
Hypothermia versus normothermia in patients with cardiac arrest and shockable rhythm: a secondary analysis of the TTM-2 studyFabio Silvio Taccone, Alain Cariou, Stefano Zorzi, et al.
Resuscitation Plus|June 18, 2025
Psychometric evaluation of EQ-5D-5L in OHCA survivors from the TTM2 trial: a <i>post hoc</i> analysisMattias Bohm, Kristofer Årestedt, Susann Ullén, et al.
Journal of the American Heart Association|January 26, 2021
Achieving Optimal Medical Therapy: Insights From the ORBITA TrialMichael Foley, Christopher A Rajkumar, Matthew Shun-Shin, et al.
Pageof 14